Please provide your email address to receive an email when new articles are posted on . Once-monthly subcutaneous octreotide was associated with persistent control of IGF-I and growth hormone levels ...
An investigational treatment for acromegaly -- also known as gigantism -- was safe and boosted biochemical control, according to final topline findings of the phase III ACROINNOVA 2 study. Meeting the ...
Positive Results from MTD201-102 Study Support Subcutaneous Route for Long-Acting Octreotide Product ABINGDON, OXFORDSHIRE / ACCESSWIRE / January 8, 2020 / Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback